Genesis of clone size heterogeneity in megakaryocytic and other hemopoietic colonies: The stochastic model revisited

Experimental Hematology

Volumn 29, Issue 11, 2001, Pages 1256-1269

  Paulus, Jean Michel ^a,d   Levin, Jack ^b   Debili, Najet ^c   Albert, Adelin ^a   Vainchenker, William ^c  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUT GUSTAVE ROUSSY   (France)

^d Laboratory of Hematology   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; CELL HETEROGENEITY; CELL LINEAGE; CELL PROLIFERATION; CELL SYNCHRONIZATION; COLONY FORMATION; ERYTHROID CELL; GENE CONTROL; HEMATOPOIESIS; HUMAN; MEGAKARYOCYTE; MEGAKARYOPOIESIS; MOLECULAR CLONING; MOLECULAR SIZE; NONHUMAN; POLYPLOIDY; PRIORITY JOURNAL; PROBABILITY; REGULATOR GENE; STEM CELL; STOCHASTIC MODEL; THROMBOCYTOPOIESIS;

EID: 0034767186     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00728-7     Document Type: Review

References (192)

1. Regulation of growth and differentiation in haemopoietic colonies growing in agar
2. Heterogeneity of in vitro colony- and cluster-forming cells in the mouse marrow: Segregation by velocity sedimentation
3. Clonal analysis of proliferation and differentiation of paired daughter cells: Action of granulocyte-macrophage colony-stimulating factor on granulocyte-macrophage precursors
4. Clone size potential and sensitivity to colony-stimulating activity: Differentiation-linked properties of granulocyte-macrophage progenitor cells
5. The granulocyte-macrophage colony-stimulating factors
6. The kinetics of colony formation by CFU-GM in vitro
7. Improved plasma culture system for production of erythrocytic colonies in vitro: Quantitative assay method for CFU-E
8. Erythropoietin sensitivity as a differentiation marker in the hemopoietic system: Studies of three erythropoietic colony responses in culture
9. Human marrow erythropoiesis in culture: II. Heterogeneity in the morphology, time course of colony formation, and sedimentation velocities of the colony-forming cells
10. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera
11. Stochastic branching model for hemopoietic progenitor cell differentiation
12. Programmed cell death (apoptosis) in hematopoiesis
13. Growth of mouse megakaryocyte colonies in vitro
14. Induction of megakaryocyte colonies with platelet formation in vitro
15. Characteristics of murine megakaryocytic colonies in vitro
16. Measurement of ploidy distribution in megakaryocyte colonies obtained from culture: With studies of the effects of thrombocytopenia
17. Polyploid megakaryocytes develop randomly from a multicompartmental system of committed progenitors
18. Kinetic analysis of megakaryocyte numbers and ploidy levels in developing colonies from mouse bone marrow cells
19. Characterization of megakaryocyte spleen colony-forming units by response to 5-fluorouracil and by unit gravity sedimentation
20. The genesis of clonal heterogeneity in megakaryocyte colonies
21. Fluorescence cytophotometric analysis of megakaryocytic ploidy in culture: Studies of normal and thrombocytopenic mice
22. Phorbol diesters stimulate the development of an early murine progenitor cell. The burst-forming unit-megakaryocyte
23. Ultrastructural analysis of murine megakaryocyte maturation in vitro: Comparison of big-cell and heterogeneous megakaryocyte colonies
24. Analysis of murine megakaryocyte colony size and ploidy: Effects of interleukin-3
25. Induction of mixed erythroid-megakaryocyte colonies and bipotential blast cell colonies by recombinant human erythropoietin in serum-free culture
26. Classes of primitive murine megakaryocytic progenitor cells
27. Factors regulating megakaryocyte progenitor commitment to polyploidization
28. The relative population sizes of megakaryocytic cells in mouse bone marrow as determined by mpl ligand responsiveness
29. Characteristics of rat megakaryocyte colonies and their progenitors in agar culture
30. Growth of human megakaryocyte colonies in culture from fetal, neonatal, and adult peripheral blood cells: Ultrastructural analysis
31. Normal human serum contains a factor(s) capable of inhibiting megakaryocyte colony formation
32. Interrelationship between mitosis and endomitosis in cultures of human megakaryocyte progenitor cells
33. Characterization of the human burst-forming unit-megakaryocyte
34. Modeling megakaryocyte development as a branching process
35. Control and implications of polyploidization in human megakaryocytes
36. Cytokine regulation of the human burst-forming unit-megakaryocyte
37. Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro
38. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors
39. The Mpl receptor is expressed in the megakaryocytic lineage from late progenitors to platelets
40. Characterization of a bipotent erythro-megakaryocytic progenitor in human bone marrow
41. The development of human megakaryocytes: III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3
42. Human megakaryocyte progenitor cells
43. Stimulation of human haemopoietic cells by colony stimulating factors: Sensitivity of leukaemic cells
44. On the maturation order of AML cells: A distinction on the basis of self-renewal properties and immunologic phenotypes
45. The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia
46. Identification of megakaryocytes, macrophages, and eosinophils in colonies of human bone marrow containing neutrophilic granulocytes and erythroblasts
47. Self-renewal of hemopoietic stem cells during mixed colony formation in vitro
48. A stochastic model of self-renewal and commitment to differentiation of the primitive hemopoietic stem cells in culture
49. Proliferative kinetics and differentiation of murine blast cell colonies in culture: Evidence for variable G0 periods and constant doubling rates of early pluripotent hemopoietic progenitors
50. Analysis of differentiation of mouse hemopoietic stem cells in culture by sequential replating of paired progenitors
51. Single cell origin of multilineage colonies in culture. Evidence that differentiation of multipotent progenitors and restriction of proliferative potential of monopotent progenitors are stochastic processes
52. Disparate differentiation in hemopoietic colonies derived from human paired progenitors
53. Differentiation and proliferation of hematopoietic stem cells
54. Stem cell renewal and determination during clonal expansion in normal and leukaemic haemopoiesis
55. Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver cells
56. Lineage commitment in the progeny of murine hematopoietic preprogenitor cells: Influence of thrombopoietin and interleukin 5
57. Evidence that hematopoiesis may be a stochastic process in vivo
58. Stem cells, pre-progenitor cells and lineage-committed cells: Are our dogmas correct?
59. Cellular immunity in vitro. Clonal proliferation of antigen-stimulated lymphocytes
60. Regulation of self-renewal of human T lymphocyte colony-forming units (TL-CFUs)
61. Analysis of pure and mixed murine mast cell colonies
62. Disparate differentiation in mouse hemopoietic colonies derived from paired progenitors
63. Stochastic model for multipotent hemopoietic progenitor differentiation
64. Mechanisms responsible for size differences between hemopoietic colonies: An analysis using a CSF-dependent hemopoietic cell line
65. Physical separation of hemopoietic stem cells differing in their capacity for self renewal
66. Differentiation in erythroleukemic cells and their somatic hybrids
67. The heritable nature of clonal characteristics in acute myeloblastic leukemia
68. The interleukin-2 T-cell system: A new cell growth model
69. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: A mechanism for controlled rates of erythrocyte production
70. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
71. Cell growth signal transduction is quantal
72. Signal transduction by the receptors for thrombopoietin (c-mpl) and interleukin-3 hematopoietic and nonhematopoietic cells
73. Inhibition of the erythropoietin-induced erythroid differentiation by granulocyte-macrophage colony-stimulating factor in the human UT-7 cell line is not due to a negative regulation of the erythropoietin receptor
74. Cell-intrinsic timers and thyroid hormone regulate the probability of cell-cycle withdrawal and differentiation of oligodendrocyte precursor cells
75. Telomere length predicts replicative capacity of human fibroblasts
76. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age
77. Telomere length and proliferation potential of hematopoietic stem cells
78. Differential expression of telomerase activity in hematopoietic progenitors from adult human bone marrow
79. Telomerase regulation, cell cycle, and telomere stability in primitive hematopoietic cells
80. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells
81. The self renewal probability of hemopoietic stem cells
82. Commitment to erythroid differentiation by Friend erythroleukemia cells: A stochastic analysis
83. Distribution of the number of cells in a clone - A Monte Carlo calculation
84. Loss of division potential in vitro: Aging or differentiation?
85. Intraclonal variation in proliferative potential of human diploid fibroblasts: Stochastic mechanism for cellular aging
86. Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis
87. Social controls on cell survival and cell death
88. Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors
89. Thrombopoietin-induced polyploidization of bone marrow megakaryocytes is due to a unique regulatory mechanism in late mitosis
90. Endomitosis of human megakaryocytes are due to abortive mitosis
91. Polyploidy: Occurrence in nature, mechanisms, and significance for the megakaryocyte-platelet system
92. Immature megakaryocytes in the mouse: In vitro relationship to megakaryocyte progenitor cells and mature megakaryocytes
93. Stromal cell-derived factor-1 (SDF-1) acts together with thrombopoietin to enhance the development of megakaryocytic progenitor cells (CFU-MK)
94. Thrombopoietin, the Mpl ligand, is essential for full megakaryocyte development
95. Haemopoietic growth factors stimulating murine megakaryocytopoiesis: Interleukin-3 is immunologically distinct from megakaryocyte-potentiator
96. Studies on paracrine regulation of murine megakaryocytopoiesis
97. The effect of interleukin 3 and GM-CSA-2 on megakaryocyte and myeloid clonal colony formation
98. Clonal proliferation of murine lymphohemopoietic progenitors in culture
99. Effect of human recombinant erythropoietin on human marrow megakaryocyte colony formation in vitro
100. Regulators of thrombopoiesis: Their biochemistry and physiology
101. Ploidization of megakaryocyte progenitors in vitro
102. The effects of thrombopoietin on megakaryocyte-CFC, megakaryocytes, and thrombopoiesis: With studies of ploidy and platelet size
103. Thrombokinetics in man
104. Effects of thrombocytopenia on megakaryocytopoiesis
105. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells
106. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD
107. Transcription factors regulating early hematopoietic development and lineage commitment
108. WAF1/Cipl by STAT5
109. Ultrasensitivity in the mitogen-activated protein kinase cascade
110. The biochemical basis of an all-or-none cell fate switch in Xenopus oocytes
111. Sustained activation of the extracellular signal-regulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells
112. Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells
113. Control of the thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway
114. The megakaryocyte/platelet specific enhancer of the α2β1 integrin gene: Two tandem AP1 sites and the mitogen-activated protein kinase signaling cascade
115. Megakaryocyte growth and development factor-induced proliferation and differentiation are regulated by the mitogen-activated protein kinase pathway in primitive cord blood hematopoietic progenitors
116. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors
117. On the choice of a mathematical model to represent normal bacterial growth
118. The distribution of colony-forming cells among spleen colonies
119. On the generalized "birth and death" process
120. Proliferation kinetics of early hemopoietic precursor cells with self-sustaining capacity in the mouse, studied with 125-I-labeled iodo-deoxyuridine
121. Hematopoietic stem proliferative behavior as revealed by bromodeoxyuridine labeling
122. CFU-S kinetics observed in vivo by bromodeoxyuridine and near-UV light treatment
123. Mechanisms and consequences of activation of protein kinase B/Akt
124. p21-activated kinase 1 phosphorylates the death agonist bad and protects cells from apoptosis
125. Regulation of bad phosphorylation and association with Bcl-x(L) by the MAPK/Erk kinase
126. Thrombopoietin, but not erythropoietin promotes viability and inhibits apoptosis of multipotent murine hematopoietic progenitor cells in vitro
127. - bone marrow cells with multilineage potential at the single-cell level: Key role of thrombopoietin
128. In vitro senescence and apoptotic cell death of human megakaryocytes
129. Stem cell factor retards differentiation of normal human erythroid progenitor cells while stimulating proliferation
130. Cell size control and a cell-intrinsic maturation program in proliferating oligodendrocyte precursor cells
131. The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells
132. In vitro effects of hematopoietic growth factors on the proliferation, endoreplication, and maturation of human megakaryocytes
133. Relationship of small acetylcholinesterase positive cells to megakaryocytes and clonable megakaryocytic progenitor cells
134. Human megakaryocytic progenitors (CFU-M) assayed in methylcellulose: Physical characteristics and requirements for growth
135. Separation of murine megakaryocytes and their progenitors on continuous gradients of Percoll
136. Inhibitory effects of interferon on mouse megakaryocytic progenitor cells in culture
137. Discussion
138. Terminal differentiation in human promyelocytic leukaemic cells in the absence of DNA synthesis
139. Induction of differentiation of HL-60 cells by dimethyl sulfoxide: Evidence for a stochastic model not linked to the cell division cycle
140. DNA synthesis is not required for the commitment of murine erythroleukemia cells
141. Differentiation in mouse melanoma cells: Initial reversibility and an on-off stochastic model
142. Interleukin 3 promotes the differentiation of isolated single megakaryocytes
143. Cytokine production and function in c-mpl-deficient mice: No physiologic role for interleukin-3 in residual megakaryocyte and platelet production
144. Identification of a light density murine megakaryocyte progenitor (LD-CFU-M)
145. Separation of the erythropoietin-responsive progenitors BFU-E and CFU-E in mouse bone marrow by unit gravity sedimentation
146. Regulation of megakaryocytopoiesis
147. Detection of a primitive megakaryocyte progenitor cell in human fetal bone marrow
148. Hierarchical structure of human megakaryocyte progenitor cells
149. Chromosome marker evidence for the bipotentiality of BFU-E
150. Megakaryocytic and erythrocytic cell lines share a common precursor cell
151. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors
152. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy
153. Stochastic expression of fetal hemoglobin in adult erythroid cells
154. Developmental changes in human megakaryocyte ploidy
155. Genetic instability of cancer cells is proportional to their degree of aneuploidy
156. Thrombopoietin-induced activation of the mitogen-activated protein kinase (MAPK) pathway in normal megakaryocytes: Role in endomitosis
157. Telomerase, cell immortality, and cancer
158. Symmetry of initial cell divisions among primitive hematopoietic progenitor is independent of ontogenic age and regulatory molecules
159. Erythropoiesis: Comparison of in vivo and in vitro amplification
160. Clonal analysis of oligodendrocyte development in culture: Evidence for a developmental clock that counts cell divisions
161. The expression of ABH antigens during in vitro megakaryocyte maturation: Origin of heterogeneity of antigen density
162. Spindle orientation and asymmetric cell fate
163. Mechanisms of asymmetric cell division: Two Bs or not two Bs, that is the question
164. Inscuteable and Staufen mediate asymmetric localization and segregation of prospero RNA during Drosophila neuroblast cell divisions
165. Miranda directs prospero to a daughter cell during Drosophila asymmetric divisions
166. Rotation and asymmetry of the mitotic spindle direct asymmetric cell division in the developing central nervous system
167. Lineage commitment in human hemopoiesis involves asymmetric cell division of multipotent progenitors and does not appear to be influenced by cytokines
168. Animal cells: Noncorrelation of length of G1 phase with size after mitosis
169. Non-genetic individuality: Chance in the single cell
170. Asymmetric distribution of oncogene products at mitosis
171. Cell heterogeneity during the cell cycle
172. Optimal proliferation of a hematopoietic progenitor cell line requires either costimulation with stem cell factor or increase of receptor expression that can be replaced by overexpression of Bcl-2
173. A matter of life and cell death
174. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release
175. Chaos
176. Combinatorial associations of regulatory proteins and the control of cell type in yeast
177. Transient nature of early haematopoietic spleen colonies
178. The serial cultivation of human diploid cell strains
179. Extension of life-span by introduction of telomerase into normal human cells
180. Hayflick's hypothesis: An approach to in vivo testing
181. Heterogeneity in telomere length of human chromosomes
182. Telomerase activity in hematopoietic cells is associated with self-renewal potential
183. Haemopoietic stem cells are organised for use on the basis of their generation-age
184. Proliferative capacity of murine hematopoietic stem cells
185. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype